Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for Preterm Delivery in Adenomyosis
NCT04535804Phase 1Unknown
- Sponsor
- Shanghai First Maternal and Infant Health Hospital
- Start
- Oct 2020
- Primary completion
- Sep 2022
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised, double-blind trial in adenomyosis comparing Aspirin group with Placebo group (2 arms). Primary endpoint: Preterm delivery. Status: unknown.
02
Drugs
aspirin
03
Conditions
adenomyosis
Beyond the preview
Go deeper on NCT04535804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04535804.